Christopher Nip

Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models

J. Gestwicki, Liangren Liu, Q. Wei, 2023, Pharmacological research.

Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment

Xiong Zhang, W. Murphy, Hong-Wu Chen, 2023, Journal for ImmunoTherapy of Cancer.

CD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy

Christopher Nip, Leyi Wang, Chengfei Liu, 2023, Biomedicines.